ID   WNK4_RAT                Reviewed;        1222 AA.
AC   Q7TPK6; Q810H4; Q811R5;
DT   02-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   30-AUG-2005, sequence version 3.
DT   24-JUL-2024, entry version 165.
DE   RecName: Full=Serine/threonine-protein kinase WNK4 {ECO:0000305};
DE            EC=2.7.11.1 {ECO:0000269|PubMed:16083423};
DE   AltName: Full=Protein kinase lysine-deficient 4 {ECO:0000312|RGD:631401};
DE   AltName: Full=Protein kinase with no lysine 4 {ECO:0000305};
GN   Name=Wnk4 {ECO:0000312|RGD:631401};
GN   Synonyms=Prkwnk4 {ECO:0000303|PubMed:14608358};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar Kyoto {ECO:0000269|PubMed:12642508};
RC   TISSUE=Kidney {ECO:0000312|EMBL:AAO18238.1};
RX   PubMed=12642508; DOI=10.1161/01.hyp.0000063147.92433.7d;
RA   Monti J., Zimdahl H., Schulz H., Plehm R., Ganten D., Hubner N.;
RT   "The role of Wnk4 in polygenic hypertension: a candidate gene analysis on
RT   rat chromosome 10.";
RL   Hypertension 41:938-942(2003).
RN   [2] {ECO:0000305}
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar Kyoto {ECO:0000269|PubMed:14608358};
RC   TISSUE=Kidney {ECO:0000312|EMBL:AAO38858.1};
RX   PubMed=14608358; DOI=10.1038/ng1271;
RA   Kahle K.T., Wilson F.H., Leng Q., Lalioti M.D., O'Connell A.D., Dong K.,
RA   Rapson A.K., MacGregor G.G., Giebisch G., Hebert S.C., Lifton R.P.;
RT   "WNK4 regulates the balance between renal NaCl reabsorption and K+
RT   secretion.";
RL   Nat. Genet. 35:372-376(2003).
RN   [3]
RP   FUNCTION, CATALYTIC ACTIVITY, ACTIVE SITE, AND MUTAGENESIS OF LYS-183 AND
RP   ASP-318.
RX   PubMed=16083423; DOI=10.1042/bj20051180;
RA   Vitari A.C., Deak M., Morrice N.A., Alessi D.R.;
RT   "The WNK1 and WNK4 protein kinases that are mutated in Gordon's
RT   hypertension syndrome phosphorylate and activate SPAK and OSR1 protein
RT   kinases.";
RL   Biochem. J. 391:17-24(2005).
RN   [4]
RP   ACTIVITY REGULATION, AND PHOSPHORYLATION AT SER-332.
RX   PubMed=15883153; DOI=10.1074/jbc.m502598200;
RA   Lenertz L.Y., Lee B.H., Min X., Xu B.E., Wedin K., Earnest S.,
RA   Goldsmith E.J., Cobb M.H.;
RT   "Properties of WNK1 and implications for other family members.";
RL   J. Biol. Chem. 280:26653-26658(2005).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1014, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Serine/threonine-protein kinase component of the WNK4-
CC       SPAK/OSR1 kinase cascade, which acts as a key regulator of ion
CC       transport in the distal nephron and blood pressure (By similarity). The
CC       WNK4-SPAK/OSR1 kinase cascade is composed of WNK4, which mediates
CC       phosphorylation and activation of downstream kinases OXSR1/OSR1 and
CC       STK39/SPAK (PubMed:16083423). Following activation, OXSR1/OSR1 and
CC       STK39/SPAK catalyze phosphorylation of ion cotransporters, such as
CC       SLC12A1/NKCC2, SLC12A2/NKCC1, SLC12A3/NCC, SLC12A5/KCC2 or
CC       SLC12A6/KCC3, regulating their activity (By similarity). Acts as a
CC       molecular switch that regulates the balance between renal salt
CC       reabsorption and K(+) secretion by modulating the activities of renal
CC       transporters and channels, including the Na-Cl cotransporter
CC       SLC12A3/NCC and the K(+) channel, KCNJ1/ROMK (By similarity). Regulates
CC       NaCl reabsorption in the distal nephron by activating the thiazide-
CC       sensitive Na-Cl cotransporter SLC12A3/NCC in distal convoluted tubule
CC       cells of kidney: activates SLC12A3/NCC in a OXSR1/OSR1- and STK39/SPAK-
CC       dependent process (By similarity). Also acts as a scaffold protein
CC       independently of its protein kinase activity: negatively regulates cell
CC       membrane localization of various transporters and channels (CFTR,
CC       KCNJ1/ROMK, SLC4A4, SLC26A9 and TRPV4) by clathrin-dependent
CC       endocytosis (By similarity). Also inhibits the activity of the
CC       epithelial Na(+) channel (ENaC) SCNN1A, SCNN1B, SCNN1D in a inase-
CC       independent mechanism (By similarity). May also phosphorylate NEDD4L
CC       (By similarity). {ECO:0000250|UniProtKB:Q80UE6,
CC       ECO:0000250|UniProtKB:Q96J92, ECO:0000269|PubMed:16083423}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000250|UniProtKB:Q9H4A3};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:16083423};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q9H4A3};
CC   -!- ACTIVITY REGULATION: Activation requires autophosphorylation of Ser-328
CC       and Ser-332 (PubMed:15883153). Autophosphorylation and subsequent
CC       activation is inhibited by increases in intracellular ionic strength:
CC       Cl(-) potently inhibits WNK4 kinase activity via direct binding (By
CC       similarity). Also inhibited by K(+) ions (By similarity).
CC       {ECO:0000250|UniProtKB:Q80UE6, ECO:0000250|UniProtKB:Q9JIH7,
CC       ECO:0000269|PubMed:15883153}.
CC   -!- SUBUNIT: Interacts with the C-terminal region of KCNJ1. Interacts with
CC       WNK1 and WNK3. Interacts with KLHL3. {ECO:0000250|UniProtKB:Q96J92}.
CC   -!- SUBCELLULAR LOCATION: Cell junction, tight junction
CC       {ECO:0000250|UniProtKB:Q80UE6}. Note=Present exclusively in
CC       intercellular junctions in the distal convoluted tubule and in both the
CC       cytoplasm and intercellular junctions in the cortical collecting duct.
CC       WNK4 is part of the tight junction complex.
CC       {ECO:0000250|UniProtKB:Q80UE6}.
CC   -!- DOMAIN: The RFXV motif mediates recognition with downstream kinases
CC       OXSR1/OSR1 and STK39/SPAK. {ECO:0000250|UniProtKB:Q96J92}.
CC   -!- PTM: Autophosphorylated at Ser-328 and Ser-332, promoting its
CC       activation (PubMed:15883153). Phosphorylated by WNK1 and WNK3
CC       (PubMed:15883153). Phosphorylated at Ser-572 in a MAP3K15/ASK3-
CC       dependent process in response to osmotic stress or hypotonic low-
CC       chloride stimulation (By similarity). {ECO:0000250|UniProtKB:Q9JIH7,
CC       ECO:0000269|PubMed:15883153}.
CC   -!- PTM: Ubiquitinated by the BCR(KLHL3) complex, leading to its
CC       degradation. Also ubiquitinated by the BCR(KLHL2) complex.
CC       {ECO:0000250|UniProtKB:Q96J92}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr protein
CC       kinase family. WNK subfamily. {ECO:0000255|PROSITE-ProRule:PRU00159}.
CC   -!- CAUTION: Was named WNK/'with no lysine(K)' because key residues for
CC       catalysis, including the lysine involved in ATP binding, are either not
CC       conserved or differ compared to the residues described in other kinase
CC       family proteins. {ECO:0000250|UniProtKB:Q9H4A3}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAO18238.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY187039; AAO18238.1; ALT_FRAME; mRNA.
DR   EMBL; AY192567; AAO38858.1; -; mRNA.
DR   RefSeq; NP_783169.2; NM_175579.3.
DR   AlphaFoldDB; Q7TPK6; -.
DR   SMR; Q7TPK6; -.
DR   DIP; DIP-59689N; -.
DR   IntAct; Q7TPK6; 1.
DR   STRING; 10116.ENSRNOP00000027770; -.
DR   iPTMnet; Q7TPK6; -.
DR   PhosphoSitePlus; Q7TPK6; -.
DR   jPOST; Q7TPK6; -.
DR   PaxDb; 10116-ENSRNOP00000027770; -.
DR   Ensembl; ENSRNOT00000027770.8; ENSRNOP00000027770.5; ENSRNOG00000020441.9.
DR   Ensembl; ENSRNOT00055057942; ENSRNOP00055047782; ENSRNOG00055033521.
DR   Ensembl; ENSRNOT00060026655; ENSRNOP00060021330; ENSRNOG00060015511.
DR   Ensembl; ENSRNOT00065057292; ENSRNOP00065047133; ENSRNOG00065033320.
DR   GeneID; 287715; -.
DR   KEGG; rno:287715; -.
DR   UCSC; RGD:631401; rat.
DR   AGR; RGD:631401; -.
DR   CTD; 65266; -.
DR   RGD; 631401; Wnk4.
DR   eggNOG; KOG0584; Eukaryota.
DR   GeneTree; ENSGT00940000159871; -.
DR   InParanoid; Q7TPK6; -.
DR   OrthoDB; 5478852at2759; -.
DR   PhylomeDB; Q7TPK6; -.
DR   TreeFam; TF315363; -.
DR   PRO; PR:Q7TPK6; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000020441; Expressed in kidney and 19 other cell types or tissues.
DR   ExpressionAtlas; Q7TPK6; baseline and differential.
DR   GO; GO:0005923; C:bicellular tight junction; ISS:UniProtKB.
DR   GO; GO:0044297; C:cell body; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0005829; C:cytosol; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0016020; C:membrane; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0031404; F:chloride ion binding; ISO:RGD.
DR   GO; GO:0008200; F:ion channel inhibitor activity; ISS:UniProtKB.
DR   GO; GO:0019870; F:potassium channel inhibitor activity; IBA:GO_Central.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IDA:RGD.
DR   GO; GO:0035932; P:aldosterone secretion; ISO:RGD.
DR   GO; GO:0055074; P:calcium ion homeostasis; ISO:RGD.
DR   GO; GO:0071466; P:cellular response to xenobiotic stimulus; ISO:RGD.
DR   GO; GO:0006821; P:chloride transport; ISO:RGD.
DR   GO; GO:0072156; P:distal tubule morphogenesis; ISS:UniProtKB.
DR   GO; GO:0070371; P:ERK1 and ERK2 cascade; ISO:RGD.
DR   GO; GO:0010467; P:gene expression; ISO:RGD.
DR   GO; GO:0006954; P:inflammatory response; ISO:RGD.
DR   GO; GO:0030644; P:intracellular chloride ion homeostasis; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; ISS:UniProtKB.
DR   GO; GO:0042116; P:macrophage activation; ISO:RGD.
DR   GO; GO:0050801; P:monoatomic ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0090188; P:negative regulation of pancreatic juice secretion; ISO:RGD.
DR   GO; GO:1903077; P:negative regulation of protein localization to plasma membrane; ISS:UniProtKB.
DR   GO; GO:0010766; P:negative regulation of sodium ion transport; IDA:UniProtKB.
DR   GO; GO:1903288; P:positive regulation of potassium ion import across plasma membrane; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; ISO:RGD.
DR   GO; GO:0070528; P:protein kinase C signaling; ISO:RGD.
DR   GO; GO:0008104; P:protein localization; ISO:RGD.
DR   GO; GO:0006468; P:protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0008217; P:regulation of blood pressure; ISO:RGD.
DR   GO; GO:1903764; P:regulation of potassium ion export across plasma membrane; ISO:RGD.
DR   GO; GO:0070294; P:renal sodium ion absorption; ISS:UniProtKB.
DR   GO; GO:0003096; P:renal sodium ion transport; ISS:UniProtKB.
DR   GO; GO:0002021; P:response to dietary excess; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; ISO:RGD.
DR   GO; GO:0007165; P:signal transduction; ISO:RGD.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; ISO:RGD.
DR   CDD; cd14033; STKc_WNK4; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR024678; Kinase_OSR1/WNK_CCT.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   InterPro; IPR050588; WNK_Ser-Thr_kinase.
DR   PANTHER; PTHR13902; SERINE/THREONINE-PROTEIN KINASE WNK WITH NO LYSINE -RELATED; 1.
DR   PANTHER; PTHR13902:SF114; SERINE_THREONINE-PROTEIN KINASE WNK4; 1.
DR   Pfam; PF12202; OSR1_C; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell junction; Isopeptide bond; Kinase; Nucleotide-binding;
KW   Phosphoprotein; Reference proteome; Serine/threonine-protein kinase;
KW   Tight junction; Transferase; Ubl conjugation.
FT   CHAIN           1..1222
FT                   /note="Serine/threonine-protein kinase WNK4"
FT                   /id="PRO_0000086826"
FT   DOMAIN          171..429
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..163
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          527..562
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          554..564
FT                   /note="Interaction with KLHL3"
FT                   /evidence="ECO:0000250|UniProtKB:Q96J92"
FT   REGION          591..612
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          626..679
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          747..809
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          836..873
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          927..1087
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1169..1222
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           996..999
FT                   /note="RFXV motif"
FT                   /evidence="ECO:0000250|UniProtKB:Q96J92"
FT   COMPBIAS        1..32
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        44..60
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        61..78
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        79..93
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        139..160
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        531..555
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        779..800
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        836..863
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        931..946
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        951..971
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        995..1039
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1047..1073
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1169..1183
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1194..1211
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        318
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:16083423"
FT   BINDING         181
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H4A3"
FT   BINDING         251..254
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H4A3"
FT   BINDING         301
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H4A3"
FT   MOD_RES         95
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96J92"
FT   MOD_RES         328
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q9JIH7"
FT   MOD_RES         332
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:15883153"
FT   MOD_RES         572
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q96J92"
FT   MOD_RES         1014
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         1196
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80UE6"
FT   CROSSLNK        154
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96J92"
FT   CROSSLNK        172
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96J92"
FT   CROSSLNK        183
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96J92"
FT   CROSSLNK        223
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96J92"
FT   CROSSLNK        238
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96J92"
FT   CROSSLNK        325
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96J92"
FT   CROSSLNK        384
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96J92"
FT   CROSSLNK        390
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96J92"
FT   CROSSLNK        447
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96J92"
FT   CROSSLNK        451
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96J92"
FT   CROSSLNK        990
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96J92"
FT   CROSSLNK        1123
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96J92"
FT   CROSSLNK        1136
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96J92"
FT   CROSSLNK        1137
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q96J92"
FT   MUTAGEN         183
FT                   /note="K->A: Abolished serine/threonine-protein kinase
FT                   activity and ability to phosphorylate OXSR1/OSR1 and
FT                   STK39/SPAK; when associated with A-318."
FT                   /evidence="ECO:0000269|PubMed:16083423"
FT   MUTAGEN         318
FT                   /note="D->A: Abolished serine/threonine-protein kinase
FT                   activity and ability to phosphorylate OXSR1/OSR1 and
FT                   STK39/SPAK; when associated with A-183."
FT                   /evidence="ECO:0000269|PubMed:16083423"
FT   CONFLICT        9
FT                   /note="T -> R (in Ref. 1; AAO18238)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        204
FT                   /note="T -> A (in Ref. 1; AAO18238)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        764
FT                   /note="P -> A (in Ref. 1; AAO18238)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        776
FT                   /note="A -> E (in Ref. 1; AAO18238)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1194
FT                   /note="R -> K (in Ref. 1; AAO18238)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1222 AA;  132833 MW;  E7E53DAC9D1FA446 CRC64;
     MLAPRNTETG VHMSQTEADL ALRPSPSLTS MGPTRLGPPP RRVRRFSGKA EPRPRSSRPS
     RRSSVDLGLL SSWSQPASLL PEPPDPPDSA GPMRSPPSNS KEHPEGTWTG AAPVKAADSA
     CPELTVSSGG PGSREPPRVP DAAARERRRE QEEKEDTETQ AVATSPDGRY LKFDIEIGRG
     SFKTVYRGLD TDTTVEVAWC ELQTRKLSRA ERQRFSEEVE MLKGLQHPNI VRFYDSWKSV
     LRGQVCIVLV TELMTSGTLK TYLRRFREMK PRVLQRWSRQ ILRGLHFLHS RVPPILHRDL
     KCDNVFITGP SGSVKIGDLG LATLKRASFA KSVIGTPEFM APEMYEEKYD EAVDVYAFGM
     CMLEMATSEY PYSECQNAAQ IYRKVTSGTK PNSFYKVKMP EVKEIIEGCI RTDKNERFTI
     QDLLTHAFFR EERGVHVELA EEDDGEKPGL KLWLRMEDAR RGGRPRDNQA IEFLFQLGRD
     AAEEVAQEMV ALGLVCEADY QPVARAVRER VAAIQRKREK LRKARELEVL PPDSGPPPAT
     VSMTPGPPSA FPPEPEEPEA DQHQSFLFRH ASYSSTTSDC ETDGYLSSSG FLDASDPALQ
     PPGGMPSSPA EPHLCLPSGF ALSIPRSGPG SDFSPGDSYA SDAASGLSDM GEGGQMRKNP
     VKTLRRRPRS RLRVTSVSDQ SDRVVECQLQ THNSKMVTFR FDLDGDSPEE IAAAMVYNEF
     ILPSERDGFL SRIREIIQRV ETLLKRDAGP SEATEDALSP QEEPAAMPAL PGPSDAELQR
     SISPEQRSWA AFSTSPSSPG TPLSPGTPFS PGTPPVFPCP IFPITSPSCH PYPFSQVSSN
     PCPQAPSSLL PSSSGASQVP FPSPSLPTSS PLPFSPSYPQ VPLHPASLPT CPSPPPLPST
     TAAPLLSLAS AFSLAVMTVA QSLLSPSPGL LSQSPPAPPG PLPSMPLPLA SCDQESLSAQ
     TAETENEASR NPAQPLLGDA RLAPISEEGK PQLVGRFQVT SSKEPAEPPL QPASPTLSRS
     LKLPTPQLTS ESSDTEDSAA GGPETREALA ESDRAAEGLG VAIDEEKDEG KEPQIGGSSP
     ILSQPSPVWM NYSYSSLCLS SEESESSGED EEFWAELQNL RQKHLSEVEA LQTLQKKEIE
     DLYSRLGKQP PPGIVAPAAM LSCRQRRLSK GSFPTSRRNS LQRSDLPGPG IMRRNSLSGS
     STGSQEQRAS KGVTFAGDVG RM
//
